Idexx Laboratories (IDXX) Gross Margin (2009 - 2026)

Idexx Laboratories' Gross Margin history runs 18 years deep, the most recent figure standing at 63.35% for Q1 2026.

• In Q1 2026, Gross Margin rose 92.0% year-over-year to 63.35%; the TTM figure through Mar 2026 stood at 62.05% (up 78.0% YoY), while the FY2025 annual figure was 61.8%, up 76.0% from the prior year.
• Gross Margin was 63.35% for Q1 2026 at Idexx Laboratories, up from 60.35% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 63.35% in Q1 2026 to a low of 58.36% in Q4 2023.
• Historically, Gross Margin has averaged 60.71% across 5 years, with a median of 60.35% in 2025.
• Biggest YoY gain for Gross Margin was 184 bps in 2022; the steepest drop was 91 bps in 2022.
• A 5-year view of Gross Margin shows it stood at 58.53% in 2022, then fell by 0 bps to 58.36% in 2023, then climbed by 2 bps to 59.8% in 2024, then gained by 1 bps to 60.35% in 2025, then increased by 5 bps to 63.35% in 2026.
• The last three Gross Margin figures came in at 63.35% (Q1 2026), 60.35% (Q4 2025), and 61.83% (Q3 2025), per Business Quant data.